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creativecommons.org/licenses/by-nc-nd/4.0/).Abstract Background and aims: The new visceral adiposity index (NVAI) is an indirect marker of
visceral adipose tissue recently developed using a Korean population. Here we examined the asso-
ciation of NVAI with coronary artery calcification and arterial stiffness in asymptomatic Korean
patients.
Methods and results: We analyzed data from 60,938 asymptomatic Korean adults. Odds ratios and
95% confidence intervals (CIs) for coronary artery calcification score (CACS) > 100 and brachial
eankle pulse wave velocity (baPWV) 14 m/s were calculated across NVAI tertiles using multiple
logistic regression analysis. Receiver operating characteristic (ROC) and area under the curve (AUC)
analyses were used to assess the ability of NVAI to predict moderate to high risk of cardiovascular
disease. The prevalence of moderate and high risk of cardiovascular disease increased significantly
as the NVAI tertile increased. The odds ratio (95% CI) of the highest NVAI tertile for CACS >100 was
5.840 (5.101e6.686) for men and 18.916 (11.232e31.855) for women, after adjusting for con-
founders. All NVAI AUC values were significantly higher than the AUC values for other visceral
adiposity markers.
Conclusions: This study provides the evidence that NVAI is independently and positively associated
with coronary calcification and arterial stiffness in asymptomatic Korean adults.
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Visceral adiposity index and cardiovascular disease risk 1775IntroductionCardiovascular disease is a major cause of death world-
wide. In 2019, the World Health Organization attributed
17.9 million deaths (31% of all deaths) to cardiovascular
disease alone. Obesity is a well-known risk factor for
cardiovascular disease [1e3]. Indeed, several studies
have linked visceral adipose tissue to coronary artery
disease and carotid atherosclerosis [4e6]. Although
computed tomography (CT) is used to precisely and
reliably identify visceral adipose tissue, it is expensive
and accompanied by substantial radiation exposure.
Anthropometric markers, such as body mass index (BMI),
waist circumference (WC), and waist-to-hip ratio, have
also been used, but these markers do not distinguish
between subcutaneous and visceral fat mass, and
their accuracy remains controversial in routine clinical
practice.
Considering the limitations of the aforementioned
methods for assessing visceral fat, Amato et al. devel-
oped the visceral adiposity index (VAI), which considers
BMI, WC, triglycerides (TG), and high-density lipoprotein
(HDL) cholesterol [7]. They validated the index using
abdominal magnetic resonance imaging. VAI has been
associated with insulin resistance, cardiovascular dis-
ease, cerebrovascular disease, non-alcoholic fatty liver
disease, and type 2 diabetes in Caucasian populations [7].
Additional indices have been developed for Asian pop-
ulations because of differences in fat distributions across
ethnic groups. For example, the Chinese VAI (CVAI) was
developed for Chinese individuals [8], and our group
developed the new VAI (NVAI) for Korean individuals [9].
NVAI was validated using nationally representative data
and has more predictive accuracy for atherosclerotic
cardiovascular disease risk than previously developed
indices [9].
Coronary artery calcification is an important clinical
feature of coronary atherosclerosis and implies the
presence of cardiovascular disease [10]. The coronary
artery calcification score (CACS) is a reliable, noninvasive
index for assessing cardiovascular risk and is calcula-
ted using cardiac CT [11]. Similarly, brachialeankle
pulse wave velocity (baPWV) is a useful and noninva-
sive measure of arterial stiffness and another reliable
surrogate of vascular damage and early atherosclerosis
[12].
Although several studies have demonstrated a link
between visceral adipose tissue (measured by abdominal
CT) and coronary atherosclerosis or arterial stiffness,
most of these studies were limited by their small sample
size [13,14]. To date, only one study has reported a sig-
nificant association between VAI and CACS, which was
observed only in men [13]. Furthermore, the association
of NVAI with coronary atherosclerosis and arterial stiff-
ness are not fully understood. To address this, we
examined whether NVAI is associated with CACS
and baPWV in a large group of asymptomatic Korean
individuals.Methods
Study participants
In this retrospective, observational, multicenter registry
study, we analyzed data from the Korea Initiatives on
Coronary Artery Calcification registry between December
2012 and August 2016. This registry includes data from
asymptomatic subjects who underwent a health exami-
nation at one of six healthcare centers in a self-referral
setting in South Korea. Of the 93,707 people enrolled in
the registry during the study period, we excluded in-
dividuals with a history of ischemic heart disease or stroke
(n Z 5237), or no coronary artery calcium scan results
(n Z 856). Also, we excluded 26,675 individuals with
insufficient data for calculating NVAI including those who
had no data of WC (n Z 26,613), no data of MBP (n Z 53),
and no data of TG (n Z 9). A total of 60,938 patients were
included in the final analysis (Fig. 1). The study procedures
were approved by the institutional review boards of each
participating healthcare center, which waived the need for
written informed consent because of the retrospective
nature of the study.
Data collection
Data regarding the presence of hypertension, dyslipidemia,
and diabetes mellitus, as well as smoking and exercise
status, were recorded by an experienced physician. A
smoker was defined as a current or previous smoker. An
exerciser was defined as a person who exercised at least
three times per week. Anthropometric parameters were
measured in the standing position with patients wearing
light indoor clothing and no shoes. BMI was calculated as
weight (kg) divided by height (m)2. WC was measured at
the umbilicus. Blood pressure was measured using an
automatic manometer after the patient rested for at least
5 min. Mean blood pressure (MBP) was calculated as 1/3
systolic blood pressure þ 2/3 diastolic blood pressure.
Blood samples were obtained from an antecubital vein
after a minimum 8-h fasting period (following relevant
guidelines and regulations) and were tested for low-
density lipoprotein cholesterol, HDL cholesterol, TG,
creatinine, and fasting glucose.
Coronary artery calcification score
The patients underwent coronary artery calcification
testing using a >16-slice multi-sensor CT (MSCT) scanner
(GE 64-slice Lightspeed, Siemens 16-slice Sensation, Phi-
lips Brilliance 256 iCT, or Philips Brilliance 40-channel
multi-detector). Horiguchi et al. found a high agreement
between 16-slice MSCT scanner and EBCT in CACS [15]. A
study by Kopp et al. showed that using MSCT scanners
resulted in less inter-scan variability compared to using
EBCT [16]. CACS was calculated using the Agatston scoring
system [17]. To obtain an accurate score, observers per-
formed a modification procedure to remove calcium
Figure 1 Study flowchart. NVAI, new visceral adiposity index; PWV, pulse wave velocity.
1776 D.-H. Son et al.located outside the coronary arteries. CACS was catego-
rized into four groups: very low risk, 0; low risk, 1e100;
moderate risk, 101e400; and high risk, 401. Also, prior
studies have demonstrated excellent inter-scanning
reproducibility for Agatston, mass, and volume score [18].
Brachialeankle pulse wave velocity
Arterial stiffness was assessed by determining baPWV
using an automatic waveform analyzer (Omron Healthcare
Co, Ltd) and the volume plethysmographic method. Pre-
vious study validated the use of automatic waveform
analyzer (Omron Healthcare) and demonstrated that this
method increases the reproducibility of ABI estimation
compared to manual measurement [19]. The highest
baPWV value (on either the right or left) was used for
analysis. baPWV results were categorized into three
groups according to Japanese guidelines [12]: low risk,
<14 m/s; moderate risk, 14e17.9 m/s; and high risk,
18 m/s.Visceral adiposity indices
NVAI was calculated as indicated below. For men,
1/[1 þ exp {-(-21.858þ(0.099  age)þ(0.10  WC)þ(0.12
 MBP)þ(0.006  TG)þ(-0.077  HDL))}].
For women,
1/[1 þ exp{-(-18.765þ(0.058  age)þ(0.14 
WC)þ(0.057  MBP)þ(0.004  TG)þ(-0.057  HDL))}].VAI was calculated as
[WC/{39.68þ(1.88  BMI)}]  (TG/1.03)  (1.31/HDL), for
men and [WC/{36.58þ(1.89  BMI)} ]  (TG/0.81)  (1.52/
HDL), for women.
For men, CVAI was calculated as
267.93þ(0.68  age)þ(0.03  BMI)þ(4.00  WC)þ(22 
logTG)-(16.32  HDL).
For women, CVAI was calculated as
187.32þ(1.71  age)þ(4.23  BMI)þ(1.12
 WC)þ(39.76  logTG)-(11.66  HDL).
Statistical analysis
Continuous variables are expressed as mean  standard
deviation and categorical variables are expressed as
number (percentage). Men and women were classified
into tertiles (T1 to T3) based on their NVAI (men: T1,
0.27; T2, 0.28e0.75; and T3, >0.75; women: T1, 0.02,
T2, 0.03e0.18; and T3, >0.18). Patient characteristics ac-
cording to NVAI tertiles were analyzed using weighted
one-way analysis of variance for continuous variables and
Chi-squared test for categorical variables. Pearson corre-
lation was conducted between visceral fat markers and
PWV or log-transformed CACS for the overall study pop-
ulation. Odds ratios (ORs) and 95% confidence intervals
(CIs) for moderate to high risk CACS and PWV were
calculated after adjusting for confounding variables,
including BMI, diabetes mellitus, smoking status, exercise
Visceral adiposity index and cardiovascular disease risk 1777status, and serum creatinine, across NVAI tertiles using
multiple logistic regression analysis. Receiver operating
characteristic (ROC) and area under the curve (AUC) ana-
lyses were performed without adjustment to compare the
predictability of moderate to high risk coronary artery
calcification and arterial stiffness between NVAI and pre-
vious indicators, such as BMI, WC, VAI, and CVAI. Com-
parison of ROCs was performed using the DeLong method.
Statistical analyses were performed using SPSS (version
23.0; IBM Corp., Armonk, NY, USA) and R (version 3.1.3)
software. P values < 0.05 were considered statistically
significant.Results
A total of 44,256 men and 16,682 women were included in
the analysis (Table 1). In both men and women, WC, BMI,
lipid profile values, fasting glucose, and prevalence of hy-
pertension, diabetes mellitus, and dyslipidemia were
higher in the highest NVAI tertile compared with the
lowest NVAI tertile. Prevalence of moderate to high risk
CACS, as well as moderate to high risk baPWV, also
increased significantly as NVAI tertile increased (Fig. 2). On
Pearson correlation analysis, age, WC, VAI, CVAI, and NVAI
were significantly correlated with both baPWV and log-
transformed CACS (Table 2). Age, WC, and NVAI posi-
tively correlated with both baPWV and log-transformed
CACS, whereas VAI and CVAI were negatively correlated
with log-transformed CACS.
Compared with the lowest tertile (reference group), the
OR (95% CI) of the highest NVAI tertile for CACS >100 was








Number 14,765 14,771 14,765
Age, y 46.4  8.9 51.7  8.6 55.9  9.3
WC, cm 82.5  6.2 87.6  5.9 92.3  7.1
BMI, m/kg2 23.3  2.3 24.8  2.3 26.2  2.8
Hypertension, n (%) 1502 (10.2) 3265 (22.1) 5485 (37.1)
Dyslipidemia, n (%) 1518 (10.3) 2374 (16.1) 2826 (19.1)
DM, n (%) 714 (4.8) 1273 (8.6) 1758 (11.9)
Smoker, n (%) 8130 (55.1) 8108 (54.9) 7968 (54.0)
SBP (mm Hg) 112.8  11.5 120.4  11.5 131.3  13.4
DBP (mm Hg) 70.8  8.3 77.6  8.2 84.8  9.3
LDL-C (mg/dL) 122.2  30.0 126.6  30.7 123.8  31.5
HDL-C (mg/dL) 57.7  13.0 49.3  10.0 44.0  8.7
TG (mg/dL) 103.4  46.7 137.5  66.9 185.4  118.9
Total-C (mg/dL) 196.4  32.9 198.0  34.4 197.2  36.0
Creatinine (mg/dL) 0.97  0.1 0.98  0.2 1.00  0.2
Fasting glucose (mg/dL) 94.8  16.4 100.7  20.3 106.5  24.9
CACS >100 657 (4.4) 1466 (9.9) 2611 (17.7)
baPWV 14 m/s 610 (4.1) 1087 (7.4) 1615 (10.9)
Values are mean  standard deviation or n (%). baPWV, brachialeankle puls
score; DBP, diastolic blood pressure; DM, diabetes mellitus; HDL-C, h
cholesterol; NVAI, new visceral adiposity index; SBP, systolic blood pressu
ence.for women. These ORs were adjusted for BMI, diabetes
mellitus, smoking status, exercise status, and serum
creatinine (Table 3). The OR (95% CI) of the highest NVAI
tertile compared with the lower tertile for baPWV 14 m/s
was 7.594 (6.298e9.156) for men and 12.465
(8.366e18.571) for women, after adjusting for the same
confounding factors.
The ability of NVAI to predict CACS >100 generated an
AUC of 0.717 (95% CI, 0.710e0.723) for the total popula-
tion, 0.677 (95% CI, 0.669e0.685) for men, and 0.785 (95%
CI, 0.770e0.800) for women. These values were signifi-
cantly higher than those for all other markers (Fig. 3, Table
4). Similar trends were observed for the ability of NVAI to
predict baPWV 14 m/s: the AUC was 0.679 (95% CI,
0.669e0.690) for the total population, 0.693 (95% CI,
0.681e0.706) for men, and 0.710 (95% CI, 0.689e0.731) for
women. These values were also significantly higher than
those for all other markers.Discussion
In this study, NVAI was independently associated with
coronary artery calcification and arterial stiffness in an
asymptomatic Korean population. NVAI predicted mod-
erate to high risk of cardiovascular disease more accu-
rately than other visceral adipose markers. Moreover,
NVAI had the highest AUC among all visceral adipose
markers, and the highest NVAI tertile was associated
with significantly higher odds of presenting with mod-
erate to high cardiovascular disease risk in both men and
women. This trend remained significant after adjusting









e 5560 5563 5559 e
<0.001 44.5  9.0 53.7  8.0 59.7  8.4 <0.001
<0.001 70.9  5.5 79.1  5.0 88.1  7.3 <0.001
<0.001 20.6  2.0 22.6  2.1 25.4  3.1 <0.001
<0.001 204 (3.7) 832 (15.0) 1976 (35.5) <0.001
<0.001 274 (4.9) 718 (12.9) 1037 (18.7) <0.001
<0.001 49 (0.9) 177 (3.2) 545 (9.8) <0.001
0.036 1454 (26.2) 2084 (37.5) 2219 (39.9) <0.001
<0.001 107.6  11.5 116.8  13.7 128.1  15.4 <0.001
<0.001 65.5  8.7 71.6  9.7 77.6  10.1 <0.001
<0.001 110.0  29.0 125.7  31.7 127.7  33.4 <0.001
<0.001 68.9  14.0 58.4  11.6 50.2  10.2 <0.001
<0.001 72.6  28.7 95.3  44.8 133.6  77.3 <0.001
0.001 194.1  33.9 203.5  35.4 203.4  37.3 <0.001
<0.001 0.72  0.2 0.74  0.2 0.76  0.2 <0.001
<0.001 88.4  10.3 93.0  14.4 101.6  23.7 <0.001
<0.001 31 (0.6) 158 (2.8) 558 (10.0) <0.001
<0.001 151 (2.7) 380 (6.8) 488 (8.8) <0.001
e wave velocity; BMI, body mass index; CACS, coronary artery calcium
igh-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
re; TG, triglycerides; Total-C, total cholesterol; WC, waist circumfer-
Figure 2 Coronary artery calcification score and brachialeankle pulse wave velocity according to NVAI tertile. CACS, coronary artery calcium score;
NVAI, new visceral adiposity index; PWV, pulse wave velocity.
1778 D.-H. Son et al.mellitus, smoking status, exercise status, and serum
creatinine. The relationship between NVAI and cardio-
vascular risk factors is more confirmatory than novel.
However, because NVAI adjusts for age and bloodTable 2 Pearson correlation matrix of clinical variables.
Age BMI WC VAI
Age 1
BMI 0.024a 1
WC 0.177a 0.842a 1
VAI 0.026a 0.381a 0.343a 1
CVAI 0.109a 0.272a 0.24a 0.514a
NVAI 0.377a 0.557a 0.672a 0.478a
Log (CACS) 0.277a 0.006 0.056a 0.024
baPWV 0.518a 0.015 0.094a 0.072a
baPWV, brachialeankle pulse wave velocity; BMI, body mass index; CACS,
NVAI, new visceral adiposity index; SE, standard error; VAI, visceral adipo
a Correlation is significant at the 0.01 level (two-tailed).
b Correlation is significant at the 0.05 level (two-tailed).pressure, it offers enhanced predictability over other
visceral adiposity markers. We will continue to improve
on this advantage, and research more accurate and more
advanced prediction models.CVAI NVAI Log (CACS) baPWV
1
0.397a 1
a 0.017b 0.154a 1
0.043a 0.334a 0.247a 1
coronary artery calcium score; CVAI, Chinese visceral adiposity index;
sity index.
Table 3 Odds ratios for CACS >100 and baPWV 14 m/s according to NVAI tertiles.
Odds ratio (95% CI) for CACS >100 Odds ratio (95% CI) for baPWV 14 m/s
Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3
Male
Unadjusted 1 2.366 (2.152e2.602) 4.613 (4.221e5.042) 1 2.122 (1.873e2.403) 4.921 (4.334e5.588)
Model 1a 1 2.638 (2.394e2.907) 5.641 (5.124e6.211) 1 2.693 (2.362e3.070) 8.237 (7.089e9.571)
Model 2b 1 2.712 (2.367e3.107) 5.840 (5.101e6.686) 1 2.531 (2.149e2.980) 7.594 (6.298e9.156)
Female
Unadjusted 1 5.214 (3.541e7.676) 19.900 (13.833e28.629) 1 2.532 (2.020e3.174) 6.530 (5.145e8.286)
Model 1a 1 5.605 (3.792e8.284) 23.552 (16.030e34.604) 1 3.254 (2.562e4.132) 13.170 (9.606e18.055)
Model 2b 1 4.490 (2.638e7.640) 18.916 (11.232e31.855) 1 2.980 (2.202e4.033) 12.465 (8.366e18.571)
baPWV, brachialeankle pulse wave velocity; CACS, coronary artery calcium score; CI, confidence interval.
a Adjusted for body mass index.
b Adjusted for body mass index, diabetes mellitus, smoking status, and serum creatinine.
Visceral adiposity index and cardiovascular disease risk 1779Visceral adipose tissue plays a key role in the devel-
opment of atherosclerosis via the inflammatory athero-
thrombotic pathway [20]. Excess visceral adiposity leads
to increased secretion of inflammatory cytokines (e.g.,
interleukin-6, tumor necrosis factor-alpha, plasminogen
activator inhibitor type-1) and decreased secretion of theFigure 3 Receiver operating characteristic curves of NVAI and other
brachialeankle pulse wave velocity. BMI, body mass index; CVAI, Chinese vi
adiposity index; WC, waist circumference.protective adipokine, adiponectin, which is an anti-
inflammatory and anti-atherogenic protein [21].
Many studies have demonstrated that visceral adipose
tissue is more pathogenic than subcutaneous fat in terms
of contributing to cardiometabolic complications [22].
Although CT is the gold standard for distinguishingvisceral adiposity markers for coronary artery calcium score and
sceral adiposity index; NVAI, new visceral adiposity index; VAI, visceral
Table 4 Area under the curves of NVAI and other visceral adiposity markers for CACS >100 and baPWV 14 m/s.
All (n Z 60,938) Males (n Z 44,256) Females (n Z 16,682)
AUC 95% CI AUC 95% CI AUC 95% CI
CACS >100 NVAI 0.717 0.710e0.723 0.677 0.669e0.685 0.785 0.770e0.800
CVAI 0.512 0.504e0.521 0.524 0.515e0.533 0.653 0.633e0.673
VAI 0.534 0.526e0.542 0.501 0.493e0.510 0.644 0.625e0.663
BMI 0.574 0.567e0.583 0.530 0.521e0.538 0.650 0.630e0.669
WC 0.625 0.618e0.633 0.574 0.565e0.582 0.710 0.692e0.728
baPWV 14 m/s NVAI 0.679 0.669e0.690 0.693 0.681e0.706 0.710 0.689e0.731
CVAI 0.528 0.516e0.540 0.523 0.509e0.537 0.571 0.547e0.594
VAI 0.560 0.549e0.572 0.544 0.530e0.558 0.607 0.584e0.631
BMI 0.516 0.504e0.528 0.492 0.478e0.506 0.574 0.550e0.598
WC 0.545 0.533e0.557 0.524 0.510e0.538 0.607 0.584e0.630
AUC, area under the curve; baPWV, brachialeankle pulse wave velocity; BMI, body mass index; CACS, coronary artery calcium score; CI, con-
fidence interval; CVAI, Chinese visceral adiposity index; NVAI, new visceral adiposity index; VAI, visceral adiposity index; WC, waist circum-
ference.
1780 D.-H. Son et al.visceral adipose tissue, its disadvantages include high
cost, radiation exposure, and lack of routine availability.
Thus, indirect visceral adipose tissue markers, such as
VAI, CVAI, and NVAI, have been developed. VAI was
developed using data from 315 healthy Italian adults; it
is a useful visceral adiposity marker for assessing car-
diovascular disease risk [7]. CVAI was subsequently
developed using data from 485 Chinese adults to account
for ethnic differences [8]. We previously developed NVAI
based on data from 539 healthy Korean adults and vali-
dated this index using nationwide population-based
cross-sectional survey data (n Z 29,235) [9]. NVAI
exhibited high accuracy for predicting atherosclerotic
cardiovascular events, including myocardial infarction,
angina, and stroke, in our previous study [9] and had
significantly higher prediction accuracy than CVAI in the
present study. However, as NVAI was only recently
developed, further studies are required to confirm its
efficacy for predicting cardiovascular risk.
In this study, we used CACS and baPWV as markers
of cardiovascular disease risk. The existence of calcifi-
cation at one or more coronary arteries reflects the
presence of atherosclerotic cardiovascular disease. Cor-
onary artery calcification provides a reasonable esti-
mate of total coronary atheroma, including noncalcified
plaque burden [23]. Moderate to high CACS, defined as
>100 in the present study, is associated with moderate
atherosclerotic plaque burden [18,24,25]. In a recent
study from Hungary, VAI was associated with a CACS
>100, but this association was only detected in men
[13]. Here, we found a significant association between
NVAI and CACS >100 in both men and women. The
discrepancy between studies could be attributed, in
part, to ethnic differences.
A recent meta-analysis showed that a higher baPWV (as
a measure of arterial stiffness) was associated with an
increased risk of developing cardiovascular disease [26].
High baPWV is also associated with inflammation, vascular
damage, and coronary atherosclerosis [27,28]. Although
the reference value for baPWV differs according to bloodpressure and age, baPWV 14 m/s is an established pre-
dictor of cardiovascular disease [12].
This study had limitations. First, because of its retro-
spective cross-sectional design, caution is advised when
inferring causal and temporal relationships. Second,
study participants were individuals who self-referred for
health promotion screenings; therefore, the study pop-
ulation may not be representative of the general Korean
population because of selection bias. Third, the study
population consisted of a single ethnic cohort of Korean
adults. Therefore, future studies are required to evaluate
more heterogeneous populations. Finally, since the data
were observational and collected using a cross-sectional
design, baPWV was the only tool to assess arterial stiff-
ness. Nevertheless, our study is unique in that we used a
Korean-specific visceral adipose tissue measure, NVAI, to
predict moderate to high cardiovascular disease risk
based on both CACS and baPWV in a large population of
asymptomatic adults.
In conclusion, this study provides novel evidence that
NVAI is independently and positively associated with
coronary calcification and arterial stiffness in asymptom-
atic Korean adults. Also, NVAI showed better prediction for
coronary calcification and arterial stiffness compared to
previous surrogate markers such as BMI, WC, VAI, and
CVAI in Korean population.
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